Novo Nordisk A/S : Novo Nordisk A/S -aktietilbagekøbsprogram

February 13, 2012 06:30 ET | Source: Novo Nordisk A/S Novo Nordisk A/S

For release content, please refer to the attachment.

Attachments

Selskabsmeddelelse nr 11 2012

Selskabsmeddelelse nr 11 2012...

Recommended Reading

September 29, 2026 00:35 ET | Source: Novo Nordisk A/S

Novo and Hengrui Pharma enter exclusive license agreement for once-weekly oral GLP-1/GIP dual receptor agonist HRS-1596

Novo and Hengrui Pharma enter 2.6 billion USD license agreement for obesity and diabetes pill that could potentially be taken only once every week
Read More
September 28, 2026 09:50 ET | Source: Novo Nordisk A/S

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 28 September 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Read More